ArticleMethods in molecular biology (Clifton, N.J.)2026
Aspergillus fumigatus Cell Wall: Current Advances in Structural Elucidation Methods.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Being an extracellular organelle, the fungal cell wall (CW) plays a crucial role in fungal biology by providing mechanical strength and protecting from its hostile environment. In pathogenic fungi, their CW is explored with two main objectives: (a) to develop novel antifungal molecules, as the disruption of CW leads to fungal lysis due to osmotic imbalance, and (b) to decipher fungal pathogenesis, as CW is the first fungal structure to interact with the host immune system. Aspergillus fumigatus is an airborne filamentous fungal pathogen, which causes a spectrum of infections ranging from allergic broncho-pulmonary aspergillosis (ABPA), mild aspergilloma (formation of fungal mass in preformed lung cavities, as in post-tuberculosis condition), to life-threatening chronic pulmonary aspergillosis (CPA) and invasive pulmonary aspergillosis (IPA). CPA occurs in those with an underlying lung condition, which facilitates the colonization of A. fumigatus. Whereas immunocompromised hosts are highly susceptible to IPA due to their inability to eliminate inhaled conidia reaching lung alveoli, A. fumigatus life-cycle spans between airborne spores (conidia) and hyphae. Accordingly, its CW undergoes continuous reorganization, leading to compositional changes, which pose difficulties for antifungal drugs to function efficiently or for the host immune system to mount an effective antifungal defense. Therefore, deciphering the organization of A. fumigatus CW during its dynamic state and at the molecular level is essential to study its impact against antifungal drugs and host immune defenses for the better management of aspergillosis. Focusing on these objectives, the current chapter compiles protocols for the extraction of different CW components, their quantification, and the techniques used to study the structural organization of A. fumigatus CW.
Indexed as
Identifiers
41968257What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.